text.skipToContent text.skipToNavigation
Need help? Please contact us

TheraPEAK™ X-VIVO™-10 Serum-free Hematopoietic Cell Medium

TheraPEAK™ X-VIVO™-10 Serum-free Hematopoietic Cell Medium

Catalog #: BP04-743Q

TheraPEAKTMX-VIVOTM 10, Serum free hematopoietic cell medium, with L-Glutamine, without gentamicin and phenol red, xenofree, 1 L

 

Want to request a quote or find our more information about this product including customization options?  Please fill in your request and your local sales specialist will contact you.    

Compare

223,00  EUR
BOT

Product Overview

TheraPEAKTM X-VIVOTM 10 Media formulations are designed to support slower growing, less mature cells such as hematopoetic stem cells and natural killer cells.  TheraPEAKTM X-VIVOTM 10 also supports the generation of Lymphokine activated killer (LAK) cells and peripheral blood lymphocytes (PBL).

 

TheraPEAKTMX-VIVOTM 10 Media is available as a 1X liquid in 3 convenient formulations as off the shelf catalog items.  Additional customization of packaging available.  

 

X-VIVOTM 10, catalog number (BE)04-380Q contains L-glutamine, gentamicin, and phenol red and is only available as research use only.

 

TheraPEAKTM X-VIVOTM 10, catalog number (BE)BP04-743Q contains L-glutamine but does not contain gentamicin or phenol red.

 

TheraPEAKTM X-VIVOTM 10, catalog number BE02-055Q contains L-glutamine and recombinant transferrin but does not contain gentamicin or phenol red. The recombinant transferrin replaces native human transferrin.

Request More Info

Storage and Content

1L bottle
Return to Top

SDS, CoA, and Instructions

Certificate of Analysis (CoA)

Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.

  • TechSheet - X-VIVO™ Media Systems

    Instructions for how to use the X-VIVO™ Media Series
Return to Top

Educational Material

Brochures, White Papers etc.

  • Case Study – Improving the Expansion of Patients' T Cells

    In this serum-free media case study, learn how selection of memory T cells can aid in streamlining CAR-T therapies.
Return to Top